Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

被引:309
作者
Chapman, AB
Guay-Woodford, LM
Grantham, JJ
Torres, VE
Bae, KT
Baumgarten, DA
Kenney, PJ
King, BF
Glockner, JF
Wetzel, LH
Brummer, ME
O'Neill, WC
Robbin, ML
Bennett, WM
Klahr, S
Hirschman, GH
Kimmel, PL
Thompson, PA
Miller, JP
机构
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[2] Univ Alabama Birmingham, Dept Med, Div Renal, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA
[4] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
[5] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
[6] Washington Univ, Div Biostat, St Louis, MO USA
[7] NW Renal Clin, Portland, OR USA
[8] NIDDK, NIH, Bethesda, MD USA
关键词
autosomal-dominant polycystic kidney disease; magnetic resonance imaging; renal volume; cyst volume; renal function;
D O I
10.1046/j.1523-1755.2003.00185.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Autosomal-dominant polycystic kidney disease (ADPKD) is characterized by gradual renal enlargement and cyst growth prior to loss of renal function. Standard radiographic imaging has not provided the resolution and accuracy necessary to detect small changes in renal volume or to reliably measure renal cyst volumes. The Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP) is longitudinally observing ADPKD individuals using high-resolution magnetic resonance (MR) imaging to determine if change in renal and cyst volumes can be detected over a short period of time, and if they correlate with decline in renal function early in disease. Methods. Standardization studies were conducted in phantoms and four subjects at each participating clinical center. After, in the full-scale protocol, healthy ADPKD individuals 15 to 45 years old with creatinine clearance>70 mL/min underwent standardized MR renal imaging, renal iothalamate clearance, comprehensive clinical evaluation, and determination of 24-hour urinary albumin and electrolyte excretion. Stereology was used from T1-weighted images to quantify renal volume, and region-growing thresholding was used from T2-weighted images to determine cyst volume. Renal structures were evaluated in relation to demographic, clinical, and biochemical variables using means/medians, standard deviations, and Pearson correlations. Results. Reliability coefficients for MR renal and cyst volume measurements in phantoms were 99.9% and 89.2%, respectively. In the full-scale protocol, 241 ADPKD individuals (145 women and 96 men) were enrolled. Total renal, cyst, and % cyst volume were significantly greater in each decade group. Hypertensive individuals demonstrated greater renal, cyst, and % cyst volume than normotensive subjects. Age-adjusted renal (r = -0.31, P < 0.0001), cyst (r = -0.36, P < 0.0001), and % cyst volume (r = -0.35, P < 0.0001) were inversely related to glomerular filtration rate (GFR). Age-adjusted renal volume (r = 0.42, P < 0.0001), cystic (r = 0.39, P < 0.0001, and % cyst volume (r = 0.41, P < 0.0001) were related with urinary albumin excretion. Conclusion. MR measures of renal and cyst volume are reliable and accurate in patients with ADPKD. ADPKD is characterized by significant cystic involvement that increases with age. Structure (renal and cyst volume) and function (GFR) are inversely related and directly related with the presence of hypertension and urinary albumin excretion in individuals with normal renal function.
引用
收藏
页码:1035 / 1045
页数:11
相关论文
共 26 条
[1]   Volumetric measurement of renal cysts and parenchyma using MRI: Phantoms and patients with polycystic kidney disease [J].
Bae, KT ;
Commean, PK ;
Lee, J .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2000, 24 (04) :614-619
[2]   Development of a nonisotopic capillary electrophoresis-based method for measuring glomerular filtration rate [J].
Bergert, JH ;
Liedtke, RR ;
Oda, RP ;
Landers, JP ;
Wilson, DM .
ELECTROPHORESIS, 1997, 18 (10) :1827-1835
[3]  
CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1349
[4]  
DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1
[5]   Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease [J].
Ecder, T ;
Chapman, AB ;
Brosnahan, GM ;
Edelstein, CL ;
Johnson, AM ;
Schrier, RW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03) :427-432
[6]   Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study [J].
Fick-Brosnahan, GM ;
Belz, MM ;
McFann, KK ;
Johnson, AM ;
Schrier, RW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (06) :1127-1134
[7]   RATE OF FUNCTIONAL DETERIORATION IN POLYCYSTIC KIDNEY-DISEASE [J].
FRANZ, KA ;
REUBI, FC .
KIDNEY INTERNATIONAL, 1983, 23 (03) :526-529
[8]   RENAL STRUCTURE AND HYPERTENSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY-DISEASE [J].
GABOW, PA ;
CHAPMAN, AB ;
JOHNSON, AM ;
TANGEL, DJ ;
DULEY, IT ;
KAEHNY, WD ;
MANCOJOHNSON, M ;
SCHRIER, RW .
KIDNEY INTERNATIONAL, 1990, 38 (06) :1177-1180
[9]   FACTORS AFFECTING THE PROGRESSION OF RENAL-DISEASE IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE [J].
GABOW, PA ;
JOHNSON, AM ;
KAEHNY, WD ;
KIMBERLING, WJ ;
LEZOTTE, DC ;
DULEY, IT ;
JONES, RH .
KIDNEY INTERNATIONAL, 1992, 41 (05) :1311-1319
[10]   Polycystic kidney disease: from the bedside to the gene and back [J].
Grantham, JJ .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (04) :533-542